Can we avoid chemotherapy for elderly patients with metastatic HER2+ breast cancer?

Ask a clinical question

Answers grounded in the literature and physician expertise.

Related Questions

What adjuvant therapy would you offer a postmenopausal woman with a new pT2N0 HR+/HER2+ breast cancer primary who is concurrently being treated with anastrozole/ribociclib for well controlled oligometastatic HR+/HER2- disease?

1 Answers

In patients with newly diagnosed HER2+ early breast cancer who may be eligible for both neoadjuvant or adjuvant T-DXd, what will be your standard sequencing?

44 Answers

How would you approach treatment selection for an elderly woman with de novo metastatic HER2+ breast cancer with lung and brain mets?

1 Answers

About Mednet

A community where doctors find answers to medicine's toughest questions.

Verified, credentialed physicians
45,000+ members across 23 specialties
Free CME and MOC credit

Evidence Meets Expertise

Community

Browse Specialties
Code of Conduct
AI Community Guidelines

Tools

Mednet AI
Mobile App

Company

About
Careers
Our Work
Blog

Support

FAQs
Contact Us
Programs

Legal

Privacy Policy
Terms of Service